Trade Agenus - AGEN CFD

Trading Conditions

• Type: CFD
• Spread: 0.0258
• Long position overnight funding adjustment: -0.02157%
• Short position overnight funding adjustment: -0.00065%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 3.0821
• Open: 2.9521
• 1-Year Change: 56.49%
• Day's Range: 2.9521 - 3.3721

What is Agenus (AGEN)?

Agenus is a biotechnology company focused on the development of immuno-oncology therapies. The company researches and develops treatments designed to harness the immune system to combat cancer. Its pipeline includes immune checkpoint modulators, vaccines, and antibody-based therapies. Agenus engages in collaborations and partnerships to advance its drug candidates through clinical development. The company operates within the pharmaceutical and biotechnology regulatory framework, conducting clinical trials to evaluate safety and efficacy. Agenus aims to contribute to cancer treatment options through innovative immunotherapy approaches.

Agenus Stock Price Today: Live Overview

The price today is shaped by active market trading, with Agenus currently at $3.3679. The price has ranged intraday from $2.9021 to $3.3821, reflecting a daily percentage movement of +8.4085%.

FAQ: Agenus (AGEN)

What is the current price of AGEN stock?

Agenus is currently trading at $3.3679.

Does AGEN pay dividends?

Agenus pays dividends to its shareholders.

Does AGEN have a formal corporate presence or regional headquarters in the UAE?

Agenus does not have an official regional office or subsidiary in the UAE and operates through distributors.

What is AGEN best known for?

Agenus is most famous for its immuno-oncology and vaccine development technologies.

What assets are typically shown together with AGEN?

Commonly shown alongside AGEN: Clene Inc., BlackRock TCP Capital Corp, Day One Biopharmaceuticals